APGE (Apogee Therapeutics) Other Current Liabilities: $6.25 Mil (As of Mar. 2026)


APGE Apogee Therapeutics Inc APGE
12 GF Score
Price $132.89
! 3 Warning Signs
View Full Analysis

What is Apogee Therapeutics Other Current Liabilities?

Apogee Therapeutics APGE +0.11% 12 Other Current Liabilities is $6.25 Mil as of Mar. 2026. GuruFocus rates APGE with a GF Score™ of 12/100. The stock has 3 warning signs investors should review.

Apogee Therapeutics's other current liabilities for the quarter that ended in Mar. 2026 was $6.25 Mil.

Apogee Therapeutics's quarterly other current liabilities declined from Sep. 2025 ($12.68 Mil) to Dec. 2025 ($3.66 Mil) but then increased from Dec. 2025 ($3.66 Mil) to Mar. 2026 ($6.25 Mil).

Apogee Therapeutics's annual other current liabilities increased from Dec. 2023 ($0.17 Mil) to Dec. 2024 ($1.90 Mil) and increased from Dec. 2024 ($1.90 Mil) to Dec. 2025 ($3.66 Mil).

Apogee Therapeutics Other Current Liabilities Related Terms

Apogee Therapeutics Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Apogee Therapeutics's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apogee Therapeutics Other Current Liabilities Chart

Apogee Therapeutics Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
0.52 0.17 1.90 3.66

Apogee Therapeutics Quarterly Data
Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.22 8.16 12.68 3.66 6.25
APGE
12GF Score
Apogee Therapeutics Inc APGE
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apogee Therapeutics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $6.25 Mil mean?
Apogee Therapeutics (APGE) has a Other Current Liabilities of $6.25 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Apogee Therapeutics.
Is Apogee Therapeutics' Other Current Liabilities too high?
Apogee Therapeutics' current Other Current Liabilities is $6.25 Mil. Overall, Apogee Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Apogee Therapeutics' Other Current Liabilities compare to NUVL and CORT?
Apogee Therapeutics' Other Current Liabilities of $6.25 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Apogee Therapeutics. Apogee Therapeutics's current Other Current Liabilities is $6.25 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apogee Therapeutics stock overvalued right now?
Apogee Therapeutics (APGE) has a current Other Current Liabilities of $6.25 Mil. The current Other Current Liabilities is $6.25 Mil. Apogee Therapeutics' overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Apogee Therapeutics (APGE), the current Other Current Liabilities is $6.25 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Apogee Therapeutics Business Description

Address 221 Crescent Street, Building 17, Suite 102b, Waltham, MA, USA, 02453
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
12GF Score

Get the complete analysis for APGE

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$132.89
Price